BASF Inaugurates New Pharma Technical Lab in India
BASF India Limited, subsidiary of BASF SE has inaugurated its pharma technical lab at its Innovation Campus Asia Pacific, located in Navi Mumbai, India.
Named “BASF Pharma Solutions Lab”, the facility will cater to the fast-growing pharmaceutical market in South Asia, especially generic drug manufacturing, which accounts for more than 70 percent of the sector in India.

This pharma technical lab is the fifth application lab in BASF’s global innovation network for pharmaceutical solutions, which also includes labs in Germany, North America, South America, and China.
The 200-square-meter application lab boasts technical capabilities in creating and delivering BASF’s functional solutions for drug formulation, especially in solubilization and instant & modified release. This will enable pharmaceutical manufacturers to solve drug formulation challenges such as developing fixed dose combinations, taste masking and temperature- or moisture-sensitive drugs.
Inaugurated in March of this year, the Innovation Campus Asia Pacific also houses the company’s other existing scientific disciplines. This creates the opportunity for innovation synergies to be able to meet the unique technological needs of diverse customers across South Asia.
“This technical lab in Mumbai will provide generic drug manufacturing customers with comprehensive solutions for superior product efficacy. It will also optimize the performance of raw materials in formulation,” said Tina Low, vice president, BASF nutrition & health Asia Pacific.
“South Asia, especially India, is the largest provider for generic medicines globally; and R&D is a major focus for Indian generic pharma companies, as they continue to move further up the value chain to become more competitive globally. The kind of innovation capabilities at this pharma solutions lab for generic drug manufacturing is crucial to furthering the government programs aimed at providing universal healthcare in South Asia,” said Raman Ramachandran, head South Asia and chairman and managing director, BASF India Limited.
2026-10-05
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
BASF and Evonik Rumored Potential Acquisition or Merger
-
BASF and Thailand’s NEO Corporate Enter Joint Development Partnership in Personal Care
-
BASF Raises North American Nylon Products by $0.08/lb, Fourth Price Increase in Six Months
-
First New UV Filter in Nearly 27 Years: BASF's Tinosorb® S Approved by FDA, Marking a Historic Shift for the U.S. Sunscreen Market
-
Multiple Chemical Industry Leaders Post Strong H1 Earnings Growth as Sector Profitability Revives
-
The Crop Protection Patent Cliff Is Here
-
BASF's Intensified Moves from May to June: Plant Closures, Divestitures, and Transformation in Sync
-
EU Clears Carlyle's Acquisition of BASF's Coatings Business, but Demands Divestment of Nouryon's Polysulfide Assets: What Are the Underlying Risks?
-
BASF, Covestro, Huntsman Raise MDI Prices in North America Amid Global Supply Crunch
-
BASF Launches Global Expansion Plan for Aroma Ingredients
Recommend Reading
-
Lipoid Kosmetik Announces New U.S. Market Distribution Partnership with Omya
-
BASF Technology with CFRP Lands in Nanjing: High-Performance Dispersant Production Line Officially Commissioned
-
Middle East Conflict Pushes Up Costs as Dow Warns the Chemical Industry Faces a Tougher Period
-
Lotte Chemical Plans Sale of Selected Operations in Malaysia, Indonesia, and the United States
-
Hengli Petrochemical’s Dalian Refinery Sanctioned by the U.S.
-
Business Society’s Market Outlook for Hydrogen Peroxide on August 21, 2026: Slightly Bullish
-
Business Society’s Market Outlook for Acetic Acid on August 18, 2026: Relatively Strong Performance
-
Costs Rise, DOP Prices Fluctuate Higher This Week
-
Business Society’s Market Outlook for MIBK on August 21, 2026: Narrow-Ranging Upward Trend
-
Business Society’s Market Outlook for Formic Acid on August 19, 2026: Volatile